E Moreno-Garcia
Overview
Explore the profile of E Moreno-Garcia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moreno-Garcia E, Puerta-Alcalde P, Gariup G, Fernandez-Ruiz M, Lopez Cortes L, Cuervo G, et al.
Open Forum Infect Dis
. 2022 May;
9(6):ofac180.
PMID: 35615301
[This corrects the article DOI: 10.1093/ofid/ofab250.].
2.
Moreno-Garcia E, Puerta-Alcalde P, Gariup G, Fernandez-Ruiz M, Lopez Cortes L, Cuervo G, et al.
Open Forum Infect Dis
. 2021 Jun;
8(6):ofab250.
PMID: 34104670
Background: There are no clear criteria for antifungal de-escalation after initial empirical treatments. We hypothesized that early de-escalation (ED) (within 5 days) to fluconazole is safe in fluconazole-susceptible candidemia with...
3.
Meira F, Albiach L, Carbonell C, Martin-Oterino J, Martin-Ordiales M, Linares L, et al.
Rev Esp Quimioter
. 2021 May;
34(4):337-341.
PMID: 33982984
Objective: The study aims to describe characteristics and clinical outcome of patients with SARS-CoV-2 infection that received siltuximab according to a protocol that aimed to early block the activity of...
4.
Moreno-Garcia E, Rico E, Albiach L, Aguero D, Ambrosioni J, Bodro M, et al.
Rev Esp Quimioter
. 2021 Apr;
34(3):238-244.
PMID: 33829722
Objective: In some patients the immune response triggered by SARS-CoV-2 is unbalanced, presenting an acute respiratory distress syndrome which in many cases requires intensive care unit (ICU) admission. The limitation...
5.
Moreno-Garcia E, Chumbita M, Puerta-Alcalde P, Cardozo C, Garcia-Vidal C
Rev Esp Quimioter
. 2019 Sep;
32 Suppl 2:59-62.
PMID: 31475813
Invasive fungal infection continues to be an important cause of morbidity and mortality in haematological patients. Antifungal prophylaxis in these patients has remarkably increased survival since its introduction. In recent...
6.
Viasus D, Puerta-Alcalde P, Cardozo C, Suarez-Lledo M, Rodriguez-Nunez O, Morata L, et al.
Clin Microbiol Infect
. 2019 Jul;
26(3):345-350.
PMID: 31295551
Objectives: To assess risk factors for multidrug-resistant Pseudomonas aeruginosa (MDR-PA) infection in neutropenic patients. Methods: Single-centre retrospective analysis of consecutive bloodstream infection (BSI) episodes (2004-2017, Barcelona). Two multivariate regression models...
7.
Moreno-Garcia E, Garcia Rodriguez J, Pano-Pardo J
Rev Esp Quimioter
. 2017 Sep;
30 Suppl 1:56-60.
PMID: 28882018
Increasing antibiotic resistance is one of the leading problems in the Public Agenda worldwide. In the last 20 years, the pace of antimicrobial drug development has markedly slowed leading to...